Last reviewed · How we verify
NCT05700240
Effect of Orthokeratology on Myopia Progression in French Children
trial testing orthokeratology in Myopia Progression in 64 participants. Completed in 24 December 2020.
29 June 2020
Quick facts
| Lead sponsor | Central Hospital, Nancy, France |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 64 |
| Start date | 2 November 2019 |
| Primary completion | 29 June 2020 |
| Estimated completion | 24 December 2020 |
| Sites | 1 location across France |
Drugs / interventions tested
- orthokeratology
- single-vision spectacle correction
Conditions studied
- Myopia Progression — all drugs for Myopia Progression →
Sponsor
Central Hospital, Nancy, France
Who can join
Adults 7 to 17, any sex, with Myopia Progression. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To evaluate and to compare the effect of orthokeratology (OK) on axial elongation in French myopic children.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05700240
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of orthokeratology
Trials testing the same drug.
- NCT05478356 — The Effects of Low-dose Atropine and Orthokeratology in Pediatric Myopia Control · NA · unknown
- NCT05090592 — Influence of Corneal Biomechanical Properties on Myopia Control · unknown
- NCT07294404 — Peripheral Relative Refractive Power of Orthokeratology Lenses · completed
Other recruiting trials for Myopia Progression
Currently open trials in the same condition.
- NCT07535749 — The Effect of Myopia-Control Contact Lenses in New Zealand Chinese Children · Phase 3 · recruiting
- NCT07229365 — Children's Viewing Behavior · NA · recruiting
- NCT06878118 — The A.R.R.E.S.T.® Contact Lens Study · NA · recruiting
- NCT06631339 — Optimizing Light Exposure for Myopia Prevention and Control (LightSPAN) · NA · recruiting
- NCT06708156 — The Effectiveness and Safety of Two Low-concentration Atropine Sulfate Eye Drops (0.01%/0.02%) for Delaying the Pediatri · Phase 3 · recruiting
Other Central Hospital, Nancy, France trials
Trials by the same sponsor.
- NCT06452290 — PET Biomarker Study for Antidepressant Response Prediction in Major Depressive Disorder · NA · not yet recruiting
- NCT07518498 — Hypnosis During Mechanical Ventilation Weaning · NA · not yet recruiting
- NCT07471334 — Prospective Study of Postictal Psychotic Symptoms Occuring After Video-EEG Monitoring in Focal Epilepsies · NA · not yet recruiting
- NCT07414667 — Primary Sjögren's Syndrome: Impact of Quantitative Anti-Ro52 Antibody Analysis on Patient Prognosis and Stratification ( · not yet recruiting
- NCT07415759 — Imaging of Electrical Properties by MRI: Investigation of Age-Related Changes · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05700240 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Central Hospital, Nancy, France
- Last refreshed: 26 January 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05700240.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing